Cosmos Health预计Sky Premium Life美国业务的毛利润率约为75%，现金流强劲;仅NOOR胶原蛋白预计年化收入将超过1200万美元

The Company anticipates strong gross margins of approximately 75% and significant cash flow generation from its Sky Premium Life U.S. operations. NOOR Collagen alone is projected to generate more than $12 million in annualized revenue, with additional growth expected as the Company introduces new products and expands its Sky Premium Life portfolio in the U.S. to meet strong consumer demand.